Skip to content
中文产业新闻精选评分68Chinese source

诺和诺德CagriSema头对头替尔泊肽的Ⅲ期REIMAGINE 5研究达到主要终点

诺和诺德再加码,下一代全球减重药大战开始

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.